214 related articles for article (PubMed ID: 31959947)
1. Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice.
Recinella L; Chiavaroli A; Orlando G; Ferrante C; Marconi GD; Gesmundo I; Granata R; Cai R; Sha W; Schally AV; Brunetti L; Leone S
Sci Rep; 2020 Jan; 10(1):732. PubMed ID: 31959947
[TBL] [Abstract][Full Text] [Related]
2. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
[TBL] [Abstract][Full Text] [Related]
3. Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD.
Recinella L; Chiavaroli A; Orlando G; Ferrante C; Veschi S; Cama A; Marconi GD; Diomede F; Gesmundo I; Granata R; Cai R; Sha W; Schally AV; Brunetti L; Leone S
Mol Psychiatry; 2021 Dec; 26(12):7465-7474. PubMed ID: 34331008
[TBL] [Abstract][Full Text] [Related]
4. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG
Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366
[TBL] [Abstract][Full Text] [Related]
5. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.
Cen LP; Ng TK; Liang JJ; Xu C; Zhuang X; Liu YF; Chen SL; Xu Y; Yang Q; Yuan XL; Qin YJ; Chan SO; Chen H; Zhang M; Schally AV; Pang CP
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244423
[TBL] [Abstract][Full Text] [Related]
6. Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers.
Perez R; Schally AV; Vidaurre I; Rincon R; Block NL; Rick FG
Oncotarget; 2012 Sep; 3(9):988-97. PubMed ID: 22941871
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice.
Recinella L; Chiavaroli A; Di Valerio V; Veschi S; Orlando G; Ferrante C; Gesmundo I; Granata R; Cai R; Sha W; Schally AV; Lattanzio R; Brunetti L; Leone S
Sci Rep; 2021 Jan; 11(1):2530. PubMed ID: 33510215
[TBL] [Abstract][Full Text] [Related]
8. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI).
Kanashiro-Takeuchi RM; Takeuchi LM; Rick FG; Dulce R; Treuer AV; Florea V; Rodrigues CO; Paulino EC; Hatzistergos KE; Selem SM; Gonzalez DR; Block NL; Schally AV; Hare JM
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):559-63. PubMed ID: 22203988
[TBL] [Abstract][Full Text] [Related]
9. The effect of GHRH antagonists on human glioblastomas and their mechanism of action.
Pozsgai E; Schally AV; Zarandi M; Varga JL; Vidaurre I; Bellyei S
Int J Cancer; 2010 Nov; 127(10):2313-22. PubMed ID: 20162575
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy.
Thounaojam MC; Powell FL; Patel S; Gutsaeva DR; Tawfik A; Smith SB; Nussbaum J; Block NL; Martin PM; Schally AV; Bartoli M
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13248-13253. PubMed ID: 29180438
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-releasing hormone antagonistic analog MIA-690 stimulates food intake in mice.
Recinella L; Chiavaroli A; Orlando G; Ferrante C; Gesmundo I; Granata R; Cai R; Sha W; Schally AV; Brunetti L; Leone S
Peptides; 2021 Aug; 142():170582. PubMed ID: 34051291
[TBL] [Abstract][Full Text] [Related]
13. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
[TBL] [Abstract][Full Text] [Related]
15. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
[TBL] [Abstract][Full Text] [Related]
16. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Schally AV; Wang H; He J; Cai R; Sha W; Popovics P; Perez R; Vidaurre I; Zhang X
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12028-12033. PubMed ID: 30373845
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.
Granato G; Gesmundo I; Pedrolli F; Kasarla R; Begani L; Banfi D; Bruno S; Lopatina T; Brizzi MF; Cai R; Sha W; Ghigo E; Schally AV; Granata R
Front Immunol; 2023; 14():1231363. PubMed ID: 37649486
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway.
Guo J; Schally AV; Zarandi M; Varga J; Leung PC
Reprod Biol Endocrinol; 2010 May; 8():54. PubMed ID: 20509930
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.
Muñoz-Moreno L; Arenas MI; Carmena MJ; Schally AV; Prieto JC; Bajo AM
Invest New Drugs; 2014 Oct; 32(5):871-82. PubMed ID: 25000999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
